Brantley KD, Zeleznik OA, Rosner B, et al. Plasma Metabolomics and Breast Cancer Risk over 20 Years of Follow-up among Postmenopausal Women in the Nurses’ Health Study. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2022;31(4):839-850. doi:10.1158/1055-9965.EPI-21-1023
Metabolomics Platform
Rhee EP, Surapaneni A, Zheng Z, et al. Trans-ethnic genome-wide association study of blood metabolites in the Chronic Renal Insufficiency Cohort (CRIC) study. Kidney international. 2022;101(4):814-823. doi:10.1016/j.kint.2022.01.014
Sarzynski MA, Rice TK, Després JP, et al. The HERITAGE Family Study: A Review of the Effects of Exercise Training on Cardiometabolic Health, with Insights into Molecular Transducers. Medicine and science in sports and exercise. 2022;54(5S):S1-S43. doi:10.1249/MSS.0000000000002859
Chen TK, Coca SG, Estrella MM, et al. Longitudinal TNFR1 and TNFR2 and Kidney Outcomes: Results from AASK and VA NEPHRON-D. Journal of the American Society of Nephrology : JASN. 2022;33(5):996-1010. doi:10.1681/ASN.2021060735
Zeleznik OA, Wittenbecher C, Deik A, et al. Intrapersonal Stability of Plasma Metabolomic Profiles over 10 Years among Women. Metabolites. 2022;12(5). doi:10.3390/metabo12050372
Qi Q, Li J, Yu B, et al. Host and gut microbial tryptophan metabolism and type 2 diabetes: an integrative analysis of host genetics, diet, gut microbiome and circulating metabolites in cohort studies. Gut. 2022;71(6):1095-1105. doi:10.1136/gutjnl-2021-324053
Kachroo P, Stewart ID, Kelly RS, et al. Metabolomic profiling reveals extensive adrenal suppression due to inhaled corticosteroid therapy in asthma. Nature medicine. 2022;28(4):814-822. doi:10.1038/s41591-022-01714-5
Brown EM, Arellano-Santoyo H, Temple ER, et al. Gut microbiome ADP-ribosyltransferases are widespread phage-encoded fitness factors. Cell Host Microbe. 2021;29(9):1351-1365.e11. doi:10.1016/j.chom.2021.07.011
Lee JWJ, Plichta D, Hogstrom L, et al. Multi-omics reveal microbial determinants impacting responses to biologic therapies in inflammatory bowel disease. Cell Host Microbe. 2021;29(8):1294-1304.e4. doi:10.1016/j.chom.2021.06.019
Sidhom EH, Kim C, Kost-Alimova M, et al. Targeting a Braf/Mapk pathway rescues podocyte lipid peroxidation in CoQ-deficiency kidney disease. J Clin Invest. 2021;131(5). doi:10.1172/JCI141380